On average, physicians vote at a rate 5% lower than the general population. In a world where political decisions impact nearly every aspect of our lives, voting is crucial for creating a policy environment that allows rheumatology practices to thrive.
ACR-Led Coalition Working Toward Legislative Solutions for Underwater Biosimilars
The Underwater Biosimilars Coalition will meet with the Medicare Payment Advisory Commission to discuss concerns about inadequate reimbursement for certain biosimilars, which has limited beneficiary access to these lower-cost alternative therapies.
Resources for Practices to Fight Payer Downcoding of E/M Services
The American Medical Association and ACR Insurance Subcommittee offer support and guidance to help practices recognize and push back against downcoded payments for evaluation and management services.
Affiliate Society Council Active & Reenergized, Reports Chair Gwenesta B. Melton, MD
ASC Chair Gwenesta B. Melton, MD, shares the connections and activities that are helping the council develop stronger ties in and outside the ACR.
Congressional Action Needed to Maintain Medicare’s Extended Telehealth Services
Medicare’s extended telehealth services will expire at the end of the year unless Congress acts to continue them. Make sure your legislators know how a failure to act will harm patient access to care.
ACR Comments on 2025 Physician Fee Schedule
The ACR’s response to the Centers for Medicare & Medicaid Services addresses the likely harm of the proposed conversion factor on the solvency and stability of rheumatology practices. The comments also include recommendations on complex drug administration coding, inflation-adjusted drug rebates and extending telehealth flexibilities.
Heading to D.C. for ACR Convergence 2024? Add Your Lawmakers to Your Itinerary
If you’re headed to Washington, D.C., this November for ACR Convergence 2024, plan now to schedule meetings with your members of Congress. Your voice as a constituent can help your lawmakers understand which policies are good for healthcare as they consider a critical end-of-year funding package.
Draft FDA Guidance No Longer Requires Biosimilar Switching Studies
The updated draft guidance, released in June, would accept an assessment of why data provided meet the switching standard to demonstrate interchangeability of biosimilars
Calling Young Rheumatologist Leaders
The ACR is seeking a representative to the Young Physician Section of the AMA House of Delegates who will join the ACR’s delegation at future HOD meetings and advance issues important to rheumatology.
AWIR & ACR: Building a Strong Future Rheumatology Community
The ACR was fortunate to participate in the Association for Women in Rheumatology’s 2024 Annual Meeting in Orlando. As this relationship grows every year, the AWIR and ACR are working together to build a sustainable and inclusive rheumatology community for the future.
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 93
- Next Page »